APOBEC3G levels predict rates of progression to AIDS
2007
APOBEC3G Levels and HIV Disease Progression
Sample size: 80
publication
10 minutes
Evidence: moderate
Author Information
Author(s): Jin Xia, Wu Hulin, Smith Harold
Primary Institution: University of Rochester
Hypothesis
APOBEC3G levels predict rates of progression to AIDS.
Conclusion
Higher levels of APOBEC3G mRNA are associated with slower disease progression in HIV-infected individuals.
Supporting Evidence
- APOBEC3G inhibits HIV replication in vitro.
- Long-term nonprogressors have higher hA3G mRNA levels.
- Lower hA3G levels are correlated with faster disease progression.
Takeaway
This study looks at a protein called APOBEC3G that might help people with HIV stay healthier for longer. If you have more of this protein, you might get sick slower.
Methodology
The study compares hA3G mRNA levels in HIV-infected and uninfected individuals using a one-sample K-S test.
Limitations
The study may not account for all factors influencing HIV progression.
Participant Demographics
Participants included HIV-infected and uninfected individuals, with a focus on long-term nonprogressors.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website